WestHill Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Hold
545
0.05% 69
2026
Q1
$268K Hold
545
0.05% 65
2025
Q4
$316K Sell
545
-116
-18% -$65.6K 0.06% 59
2025
Q3
$321K Buy
661
+5
+0.8% +$2.33K 0.06% 56
2025
Q2
$266K Sell
656
-1
-0.2% -$418 0.06% 60
2025
Q1
$327K Hold
657
0.07% 53
2024
Q4
$342K Sell
657
-10
-1% -$5.5K 0.08% 52
2024
Q3
$413K Buy
667
+10
+2% +$5.92K 0.09% 48
2024
Q2
$363K Buy
657
+3
+0.5% +$1.72K 0.09% 47
2024
Q1
$380K Buy
654
+2
+0.3% +$1.12K 0.09% 50
2023
Q4
$346K Sell
652
-1
-0.2% -$484 0.09% 49
2023
Q3
$331K Sell
653
-13
-2% -$6.93K 0.1% 46
2023
Q2
$347K Hold
666
0.1% 41
2023
Q1
$384K Sell
666
-2
-0.3% -$1.13K 0.11% 40
2022
Q4
$368K Sell
668
-7
-1% -$3.71K 0.12% 42
2022
Q3
$342K Buy
675
+1
+0.1% +$560 0.12% 41
2022
Q2
$366K Sell
674
-5
-0.7% -$2.75K 0.12% 41
2022
Q1
$401K Buy
+679
New +$390K 0.12% 39

Other funds holding TMO

WestHill Financial Advisors's TMO Position: Q2 2026 in Review

WestHill Financial Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 545 shares worth $273K. The position accounts for 0.05% of the portfolio, ranked #69.

WestHill Financial Advisors first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $413K in Q3 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • WestHill Financial Advisors held 545 shares of Thermo Fisher Scientific worth $273K as of Q2 2026.
  • WestHill Financial Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.05% of WestHill Financial Advisors's portfolio in Q2 2026, its #69 holding.
  • WestHill Financial Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • WestHill Financial Advisors's Thermo Fisher Scientific position peaked at $413K in Q3 2024.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on WestHill Financial Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.